BioSpace News Archive

The DOL’s Office of Federal Contract Compliance Programs found that AstraZeneca paid a much lower base salary than similar employees to 23 Hispanic female staff and 295 female employees.

With the planned departure from its 561,652-square-foot RTP campus, GSK will reduce its geographical footprint, but not its staff.

Filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic COVID-19 with long-acting antibody combination (non-vaccine)

CLN7 program currently in Phase 1 clinical proof-of-concept trial with preliminary data anticipated by year-end 2021

GE Healthcare Receives FDA Approval for Change in Contraindications in Prescribing Information for Optison TM

Mydecine Innovations Group announced that it plans to supply its lead drug candidate, MYCO-001, for a multi-site smoking cessation study being conducted at Johns Hopkins University, New York University and the University of Alabama Birmingham by leading drug and substance use researcher, Dr. Matthew Johnson.

Harpoon Therapeutics, Inc. today announced that an abstract with preclinical data of its TriTAC-XR T cell engager platform has been accepted for poster presentation at the 36th Annual Meeting of the Society for Immunotherapy of Cancer (SITC).

Humacyte, Inc. today announced that senior leadership will present at seven scientific and industry events in October 2021.

Biohaven Pharmaceutical Holding Company Ltd. today announced preliminary net product revenue of NURTEC ODT (rimegepant) for the third quarter of 2021.

DTx Pharma, Inc. announced that Dr. Arthur Suckow, Co-Founder and CEO, will present at the Ophthalmology Innovation Summit’s Retina Innovation Showcase on October 7, 2021, during the Annual Scientific Meeting of the American Society of Retina Specialists.